nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Changes in GABAA receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem
|
Follesa, P |
|
2002 |
42 |
2 |
p. 191-198 8 p. |
artikel |
2 |
Characterization of calcitonin gene-related peptide (CGRP) receptors and their receptor-activity-modifying proteins (RAMPs) in human brain microvascular and astroglial cells in culture
|
Moreno, Mariá Jesús |
|
2002 |
42 |
2 |
p. 270-280 11 p. |
artikel |
3 |
Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats
|
Shannon, Harlan E. |
|
2002 |
42 |
2 |
p. 253-261 9 p. |
artikel |
4 |
Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)2 receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT2A receptor mediation of the HPA axis
|
Hemrick-Luecke, Susan K. |
|
2002 |
42 |
2 |
p. 162-169 8 p. |
artikel |
5 |
Electroencephalographic activation by fluoxetine in rats: role of 5-HT1A receptors and enhancement of concurrent acetylcholinesterase inhibitor treatment
|
Dringenberg, Hans C. |
|
2002 |
42 |
2 |
p. 154-161 8 p. |
artikel |
6 |
Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonist
|
Lazzaro, J.T. |
|
2002 |
42 |
2 |
p. 143-153 11 p. |
artikel |
7 |
5-HT6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine
|
Frantz, K.J |
|
2002 |
42 |
2 |
p. 170-180 11 p. |
artikel |
8 |
Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats
|
Li, Simon Xi-Ming |
|
2002 |
42 |
2 |
p. 181-190 10 p. |
artikel |
9 |
Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex
|
Fink, Klaus |
|
2002 |
42 |
2 |
p. 229-236 8 p. |
artikel |
10 |
Inhibition of the potassium current IKSO, in cerebellar granule cells, by the inhibitors of MEK1 activation, PD 98059 and U 0126
|
Boyd, D.F. |
|
2002 |
42 |
2 |
p. 221-228 8 p. |
artikel |
11 |
Involvement of adrenoceptors in the angiotensin II-induced expression of inducible transcription factors in the rat forebrain and hypothalamus
|
Blume, A |
|
2002 |
42 |
2 |
p. 281-288 8 p. |
artikel |
12 |
Neuroprotective agent riluzole potentiates postsynaptic GABAA receptor function
|
He, Y. |
|
2002 |
42 |
2 |
p. 199-209 11 p. |
artikel |
13 |
[Nphe1]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices
|
Chiou, Lih-Chu |
|
2002 |
42 |
2 |
p. 246-252 7 p. |
artikel |
14 |
SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
|
Cools, A.R. |
|
2002 |
42 |
2 |
p. 237-245 9 p. |
artikel |
15 |
Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents
|
Zhang, Bo |
|
2002 |
42 |
2 |
p. 262-269 8 p. |
artikel |
16 |
Two new actions of topiramate: inhibition of depolarizing GABAA-mediated responses and activation of a potassium conductance
|
Herrero, Ana I. |
|
2002 |
42 |
2 |
p. 210-220 11 p. |
artikel |